ArticleJournal of clinical pharmacology2015

Population pharmacokinetic analysis of raltegravir pediatric formulations in HIV-infected children 4 weeks to 18 years of age.

Matthew L Rizk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.